Immune checkpoint inhibitor-based combination therapy for colorectal cancer: an overview

J Li, X Xu - International Journal of General Medicine, 2023 - Taylor & Francis
Colorectal cancer (CRC) is one of the most common diseases in the world. Tumor
immunotherapy is an innovative cancer treatment that acts by activating the human body's …

[HTML][HTML] Circulating natural killer cells as prognostic value for non-small-cell lung cancer patients treated with immune checkpoint inhibitors: correlation with …

M Tenuta, C Pandozzi, F Sciarra, F Campolo… - Cancers, 2023 - mdpi.com
Simple Summary In this study, we provide a basal and longitudinal evaluation of immune
cells in advanced non-small-cell lung cancer (NSCLC) patients undergoing PD-1 or PD-L1 …

Sarcopenia in Lung Cancer: A Narrative Review

U Jogiat, Z Jimoh, SR Turner, V Baracos… - Nutrition and …, 2023 - Taylor & Francis
It has been over 10 years since the relationship between sarcopenia and lung cancer was
first explored. Since then, sarcopenia research has progressed substantially, and the …

Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors

C Liu, H Zhao, R Zhang, Z Guo… - Oncology …, 2023 - spandidos-publications.com
The emergence of immune checkpoint inhibitors (ICIs) has provided a new treatment option
for patients with hepatocellular carcinoma (HCC). However, further evaluation is needed for …

[HTML][HTML] Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity

EG Pizzutilo, R Romanò, L Roazzi, AG Agostara… - Cancer Research, 2023 - AACR
Cancer immunotherapy, largely represented by immune checkpoint inhibitors (ICI), has led
to substantial changes in preclinical cancer research and clinical oncology practice over the …

[PDF][PDF] 血肌酐与胱氨酸抑素C 比值对晚期非小细胞肺癌肌肉减少症的诊断价值

沈丽丽, 蔡锦洪, 包亚红, 李倩倩, 刘剑辉 - 肿瘤代谢与营养电子杂志 - 182.92.200.144
目的本研究旨在探讨血肌酐(Cr) 与胱氨酸抑素C (CysC) 比值对晚期非小细胞肺癌(NSCLC)
患者肌肉减少症的预测价值. 方法本研究选取2019 年1 月至2022 年1 月期间于南通大学附属 …

Thoracic Sarcopenia Was a Poor Prognostic Predictor in Patients Receiving Immunotherapy for Advanced Non-Small-Cell Lung Cancer

M Wang, P Yang, L Zhou, Z Feng - Available at SSRN 4793604 - papers.ssrn.com
Objectives: Sarcopenia, as measured at the level of the third lumbar vertebra (L3) has been
shown to predict the survival of cancer patients. However, many patients with advanced non …